ARTV · Forms 3, 4, 5
Insider trades at Artiva Biotherapeutics, Inc.
4 insiders sold $726K of Artiva Biotherapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Artiva Biotherapeutics, Inc. (ARTV) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Fred Aslan | Chief Executive Officer | Sell (10b5-1 plan) | 23,463 | $7.20 | $169K | Form 4 | |
| Christopher Horan | Chief Tech Operations Officer | Sell | 10,340 | $6.84 | $71K | Form 4 | |
| Jennifer Bush | COO, CLO, Compliance Officer | Sell | 8,370 | $6.84 | $57K | Form 4 | |
| Subhashis Banerjee | Chief Medical Officer | Sell | 1,099 | $6.84 | $8K | Form 4 | |
| Fred Aslan | Chief Executive Officer | Sell | 61,696 | $6.84 | $422K | Form 4 | |
| Fred Aslan | Chief Executive Officer | Award | 110,000 | Form 4 | |||
| RA CAPITAL MANAGEMENT, L.P. | Director | Options or other derivatives | Form 4 | ||||
| Laura Stoppel | Director | Options or other derivatives | Form 4 | ||||
| Elaine K. Sorg | Director | Options or other derivatives | Form 4 | ||||
| Elizabeth L Hougen | Director | Options or other derivatives | Form 4 | ||||
| Brian Daniels | Director | Options or other derivatives | Form 4 | ||||
| Daniel G. Baker | Director | Options or other derivatives | Form 4 | ||||
| Alison Moore | Director | Options or other derivatives | Form 4 | ||||
| Fred Aslan | Chief Executive Officer | Award | 45,000 | Form 4 | |||
| Gines Diego Miralles | President & Head of R&D | Award | 45,000 | Form 4 | |||
| Christopher Horan | Chief Tech Operations Officer | Award | 40,000 | Form 4 | |||
| Jennifer Bush | COO, CLO, Compliance Officer | Award | 45,000 | Form 4 | |||
| Subhashis Banerjee | Chief Medical Officer | Award | 30,000 | Form 4 | |||
| Fred Aslan | Chief Executive Officer | Sell (10b5-1 plan) | 23,429 | $10.92 | $256K | Form 4 | |
| RA CAPITAL MANAGEMENT, L.P. | Director | Options or other derivatives | Form 4 | ||||
| Laura Stoppel | Director | Options or other derivatives | Form 4 | ||||
| Elaine K. Sorg | Director | Options or other derivatives | Form 4 | ||||
| Elizabeth L Hougen | Director | Options or other derivatives | Form 4 | ||||
| Brian Daniels | Director | Options or other derivatives | Form 4 | ||||
| Daniel G. Baker | Director | Options or other derivatives | Form 4 | ||||
| Alison Moore | Director | Options or other derivatives | Form 4 | ||||
| Christopher Horan | Chief Tech Operations Officer | Sell | 10,366 | $11.16 | $116K | Form 4 | |
| Jennifer Bush | COO, CLO, Compliance Officer | Sell | 8,391 | $11.16 | $94K | Form 4 | |
| Subhashis Banerjee | Chief Medical Officer | Sell | 1,100 | $11.16 | $12K | Form 4 | |
| Fred Aslan | Chief Executive Officer | Sell | 61,888 | $11.16 | $690K | Form 4 | |
| Subhashis Banerjee | Chief Medical Officer | Option exercise | 5,306 | $1.92 | $10K | Form 4 | |
| Subhashis Banerjee | Chief Medical Officer | Sell (10b5-1 plan) | 8,222 | $12.01 | $99K | Form 4 | |
| Subhashis Banerjee | Chief Medical Officer | Option exercise | 429 | $1.92 | $824 | Form 4 | |
| Subhashis Banerjee | Chief Medical Officer | Sell (10b5-1 plan) | 429 | $12.00 | $5K | Form 4 | |
| RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 24,944 | $9.93 | $248K | Form 4 | |
| RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 20,824 | $9.99 | $208K | Form 4 | |
| RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 41,319 | $9.99 | $413K | Form 4 | |
| RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 59,880 | $9.96 | $596K | Form 4 | |
| RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 84,124 | $9.93 | $835K | Form 4 | |
| RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 120,582 | $9.55 | $1.2M | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.